Skip to main content

VaxiJen Dataset of Bacterial Immunogens: An Update

Buy Article:

$68.00 + tax (Refund Policy)

Background: Identifying immunogenic proteins is the first stage in vaccine design and development. VaxiJen is the most widely used and highly cited server for immunogenicity prediction. As the developers of VaxiJen, we are obliged to update and improve it regularly. Here, we present an updated dataset of bacterial immunogens containing 317 experimentally proven immunogenic proteins of bacterial origin, of which 60% have been reported during the last 10 years.

Methods: PubMed was searched for papers containing data for novel immunogenic proteins tested on humans till March 2017. Corresponding protein sequences were collected from NCBI and UniProtKB. The set was curated manually for multiple protein fragments, isoforms, and duplicates.

Results: The final curated dataset consists of 306 immunogenic proteins tested on humans derived from 47 bacterial microorganisms. Certain proteins have several isoforms. All were considered, and the total protein sequences in the set are 317. The updated set contains 206 new immunogens, compared to the previous VaxiJen bacterial dataset. The average number of immunogens per species is 6.7. The set also contains 12 fusion proteins and 41 peptide fragments and epitopes. The dataset includes the names of bacterial microorganisms, protein names, and protein sequences in FASTA format.

Conclusion: Currently, the updated VaxiJen bacterial dataset is the best known manually-curated compilation of bacterial immunogens. It is freely available at http://www.ddg-pharmfac.net/vaxi jen/dataset. It can easily be downloaded, searched, and processed. When combined with an appropriate negative dataset, this update could also serve as a training set, allowing enhanced prediction of the potential immunogenicity of unknown protein sequences.

Keywords: FASTA; Immunogenicity prediction; VaxiJen; bacterial immunogen; dataset; epitopes

Document Type: Miscellaneous

Publication date: 01 October 2019

More about this publication?
  • Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design. Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, etc., providing excellent rationales for drug development.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content